At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,737 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessing Diagnostic Value of Non-invasive FFRCT in Coronary CarE (ADVANCE)
In Brief
An observational study for Coronary Artery Disease. Completed, enrolled 4,737 participants.
Detailed Summary
The objective of the HeartFlow ADVANCE Registry is to evaluate utility, clinical outcomes and resource utilization of FFRCT-guided evaluation in clinically stable, symptomatic patients with coronary artery disease (CAD) in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in the diagnosis and management of CAD.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
First PostedJul 2015
Primary CompletionFeb 2019
Study CompletionMay 2019
TodayJul 2026
First PostedJul 16, 2015
Enrollment StartJul 1, 2015
Primary CompletionFeb 1, 2019
Study CompletionMay 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 11.0 years ago